Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 3/20 | 0.55 |
| ▸ | PARP1 | P09874 | 6/20 | 0.49 |
| ▸ | TNKS | O95271 | 5/20 | 0.49 |
| ▸ | TNKS2 | Q9H2K2 | 5/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | UBE2I | P63279 | 1/20 | 0.43 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.43 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | CTSV | O60911 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | PDE9A | O76083 | 1/20 | 0.41 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31047679 | 0.86 | SERPINE1 (0.65) | SERPINE1PARP1TNKSTNKS2MAOA | |
| SCHEMBL14867264 | 0.85 | MAOA (0.48) | SERPINE1PARP1TNKSTNKS2MAOA | |
| SCHEMBL29639169 | 0.81 | PTGS2 (0.56) | SERPINE1PARP1TNKSTNKS2RAB9A | |
| SCHEMBL29031852 | 0.81 | PTGS2 (0.56) | SERPINE1PARP1TNKSTNKS2RAB9A | |
| SCHEMBL14867250 | 0.80 | PARP1 (0.54) | SERPINE1PARP1TNKSTNKS2CDC25B | |
| SCHEMBL31047695 | 0.80 | PARP1 (0.49) | SERPINE1PARP1TNKSTNKS2CDC25B | |
| SCHEMBL29031885 | 0.79 | SERPINE1 (0.56) | SERPINE1PARP1TNKSTNKS2RAB9A | |
| SCHEMBL30472330 | 0.79 | SERPINE1 (0.56) | SERPINE1PARP1TNKSTNKS2RAB9A | |
| SCHEMBL14867286 | 0.78 | KDM4E (0.50) | SERPINE1TNKSTNKS2MAOAMAOB | |
| SCHEMBL14867248 | 0.75 | HPRT1 (0.46) | SERPINE1PARP1TNKSTNKS2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1729720-B1 | COMPOSITION COMPRISING A POLYMER COMPRISING A MONOMER COMPOUND EXHIBITING AN OPTICAL PROPERTY, METHOD MAKING USE OF SAID COMPOSITION | OREAL (FR) | 2008-11-19 | — | — | EP | disclosed |
| US-20070191562-A1 | Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound, a polymer containing said monomer compound and the use thereof | L'OREAL S.A. (FR) | 2007-08-16 | — | — | US | disclosed |
| EP-1729720-A1 | COMPOSITION COMPRISING A MONOMER COMPOUND EXHIBITING AN OPTICAL PROPERTY, METHOD MAKING USE OF SAID COMPOSITION, A MONOMER COMPOUND, A POLYMER CONTAINING SAID MONOMER COMPOUND AND THE USE THEREOF | L'OREAL (FR) | 2006-12-13 | — | — | EP | disclosed |
| WO-2006005823-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2006-01-19 | — | — | WO | disclosed |
| US-20050271616-A1 | Novel block polymers, compositions comprising them, and processes for treating kerating materials therewith | L'OREAL S.A. (FR) | 2005-12-08 | — | — | US | disclosed |
| WO-2005102249-A1 | COMPOSITION COMPRISING A MONOMER COMPOUND EXHIBITING AN OPTICAL PROPERTY, METHOD MAKING USE OF SAID COMPOSITION, A MONOMER COMPOUND, A POLYMER CONTAINING SAID MONOMER COMPOUND AND THE USE THEREOF | L'OREAL (FR) | 2005-11-03 | — | — | WO | disclosed |
| EP-1580203-A1 | New blockpolymers, compositions comprising the same and use thereof | L'OREAL (FR) | 2005-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050271616-A1 | Novel block polymers, compositions comprising them, and processes for treating kerating materials therewith | KRT18, TUBB, TUBB4B | SERPINE1 282/4885PARP1 1718/4885TNKS 1848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.